openPR Logo
Press release

Phosphatidylinositol 3-Kinase Inhibitors - Pipeline, Clinical Trials and Key Players Analysis Genentech, Novartis

12-07-2018 06:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Phosphatidylinositol 3-Kinase Inhibitors - Pipeline,

The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates in different stages of development.

Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that are involved in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules in PI3K/AKT/mTOR signaling pathway by sending chemical messengers from cell surface to cytoplasm. These signals activate multiple effector kinase pathways, resulting in survival and growth of normal cells. Phosphatidylinositol 3-kinases is categorized on the basis of classes as class I, II and III, on the basis of structure of the PI3K, based on the specificities of the substrate as well as on the basis of lipid end-product’s nature. Bases on structure, Phosphatidylinositol 3-kinases has four different forms PI3K alpha, PI3K beta, PI3K gamma and PI3K delta.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/phosphoinositide-3-kinase-inhibitor-pipeline-analysis/report-sample

In March 2017, Bayer AG presented clinical results of Phosphoinositide 3-kinase (PI3K)-targeting drug candidate Copanlisib in Phase II CHRONOS-1 trial, evaluating patients with relapsed or refractory indolent non-Hodgkin's lymphoma (iNHL), trial with NCT ID 01660451. The results across all patient groups showed an objective response rate (ORR) of 59.2%, with a 12% complete response (CR) rate and a median duration of response (DOR) of more than 98 weeks, or 687 days (range 0-687).

The research found that different companies engaged in manufacturing of PI3K inhibitors are collaborating. One of the collaborations occurred in November 2016 between Verastem, Inc. and Infinity Pharmaceuticals, Inc.

Browse report at: https://www.psmarketresearch.com/market-analysis/phosphoinositide-3-kinase-inhibitor-pipeline-analysis

The major players for PI3K inhibitors pipeline include, but are not limited to, Novartis AG, Genentech, Inc., SignalRX Pharmaceuticals Inc. and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phosphatidylinositol 3-Kinase Inhibitors - Pipeline, Clinical Trials and Key Players Analysis Genentech, Novartis here

News-ID: 1426150 • Views:

More Releases from P&S Intelligence

Neurology Had the Major Share in the AI-Based Medical imaging Market
Neurology Had the Major Share in the AI-Based Medical imaging Market
The AI-based medical imaging market will generate USD 11,921.4 million 2030, powering at a robust rate of 30.4% by the end of this decade. The key factors powering the industry include the increasing occurrence of chronic ailments, growing requirement for medical services for the elderly populace, and increasing research and development expenditure in the healthcare industry. Furthermore, the incessant progression in imaging tech and the increase in the
Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls

All 5 Releases


More Releases for PI3K

PI3K/AKT/mTor Pathway Inhibitors for Breast Cancer Market New Study Offers Insig …
This PI3K/AKT/mTor Pathway Inhibitors for Breast Cancer market analysis report aims to provide a solid platform to reduce business risks and deal with major changes take place in the business. Successful company strategies provided here help major players to expand business and make an effective business growing plan. It helps key organizations to deal with continuously changing business scenario. It eases different company activities around the company. This PI3K/AKT/mTor Pathway
JAK and PI3K Signaling Pathway Market Seeking Excellent Growth | Key Players: Ba …
Complete study of the global JAK and PI3K Signaling Pathway market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global JAK and PI3K Signaling Pathway industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed
PI3K inhibitors Market : Growth Opportunity and Industry Revenue Analysis By Maj …
Global PI3K inhibitors Market Size, Status and Forecast 2020 Our new sample is updated which correspond in new report showing impact of COVID-19 on Industry The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porter’s five techniques for analyzing the PI3K inhibitors Market; it also offers the examination of the global market. To make the report more potent and easy to understand,
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Segmentation Analysis and Glo …
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Overview Metabolism of the human body relies on a variety of factors, and proper metabolism is essential to prevent several diseases. The development of tumours inside the body is largely due to improper cycles of metabolism. Medical researchers have demonstrated commendable accountability in dealing with chronic disorders and diseases. The cellular functions that run inside the body need be controlled and manoeuvred through proper drug
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Exclusive insight on Transfor …
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Overview Metabolism of the human body relies on a variety of factors, and proper metabolism is essential to prevent several diseases. The development of tumours inside the body is largely due to improper cycles of metabolism. Medical researchers have demonstrated commendable accountability in dealing with chronic disorders and diseases. The cellular functions that run inside the body need be controlled and manoeuvred through proper drug
PI3K Signaling Pathway Market Growth with Worldwide Industry Analysis Up to 2025
A new research document with title 'PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like United States, Asia-Pacific, China, Japan, India, Asia and important players/vendors.The report will help user gain market insights, future trends and growth prospects for forecast period